Jun 15, 2023· Comment from Association for Accessible Medicines (AAM)· FDA-2020-D-1057-0044
Association for Accessible Medicines (AAM) comment letter submitted to Re: Docket No. FDA-2020-D-1057; Notification of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C of the FD&C Act; Request for Comments